IDH1 and central nervous system cancer: The IDH1 mutation occurs frequently in grade II and III gliomas, and indeed, when considering only the samples positive for IDH1R132H (Fig. S1E), the median RSK1 levels were also higher in GBMs than in LGG (Fig. 1D).